찬성CRISPR와 같은 유전자 편집 기술을 인간의 유전 질환을 제거하는 데 사용해야 하는가?
The literature suggests gene editing holds transformative potential to eradicate inherited diseases, as evidenced by CRISPR’s success in correcting sickle cell mutations (Frangoul et al., 2020). While safety concerns persist, advancing precision reduces off-target risks. Ethically, the moral imperative to alleviate suffering outweighs speculative harms, particularly when therapeutic applications align with medical ethics. Equity challenges, though valid, reflect systemic issues rather than inherent technological flaws.
❤️ 7💬 1